SEC-sourced researchBeta
NPHC
NUTRA PHARMA CORP
Company comparison ↗
Data passport
- CIK
- 0001119643
- Exchange
- OTC
- Business activity
- — · SIC 2833
- Financial inputs
- 6/6
- Filing date
- Sep 2, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 246,309.0000 | May 20, 2026 |
| December 2025 | 257,612.0000 | May 20, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 257,612.0000 | -2,047,392.0000 | -1,163,964.0000 | 584,558.0000 | 17,409,864.0000 | May 20, 2026 |
| December 2024 | 246,309.0000 | -1,285,663.0000 | -423,959.0000 | 599,495.0000 | 15,407,409.0000 | May 20, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $257.61K | December 2025 | May 20, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $246.31K | December 2024 | May 20, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$2.05M | December 2025 | May 20, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$1.16M | December 2025 | May 20, 2026 | 10-K |
| Total assetsAssets | $584.56K | December 2025 | May 20, 2026 | 10-K |
| Total liabilitiesLiabilities | $17.41M | December 2025 | May 20, 2026 | 10-K |